null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-001816-42-FI

Enrollment

180

Registered

2012-05-21

Start date

2012-06-12

Completion date

Unknown

Last updated

2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10012151 Term: Degeneration of cervical intervertebral disc System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders MedDRA version: 14.1 Level: LLT Classification code 10012153 Term: Degeneration of lumbar or lumbosacral intervertebral disc System Organ Class: 10028395 - Musculos

Interventions

Trade Name: Targiniq Pharmaceutical Form: Tablet INN or Proposed INN: Oksikodonihydrokloridi CAS Number: 124-90-3 Other descriptive name

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 120 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 60

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactKuopion yliopistollinen sairaala

Kuopion yliopistollinen sairaala

hannu.kokki@kuh.fi+3580447174654

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026